Combination with Metformin or Metformin with SGLT-2 Inhibitors In a 26-week, double-blind, double-dummy trial (Trial 4, NCT02863419), 711 adult patients with type 2 diabetes mellitus on metformin alone or metformin with SGLT-2 inhibitors were randomized to semaglutide tablets 14 mg orally once daily, liraglutide 1.8 mg subcutaneous injection once daily or placebo
Make sure you coordinate with them, says Gorrepati
Choosing between tirzepatide and semaglutide depends on your goals, tolerability, and coverage landscape
This article reports that fewer than 50% of patients remain on GLP1-based therapy 1 year after initiation
Your outcome can depend on factors like adherence, lifestyle, starting health status, side effects, and individual biology